ACTA PHARMACEUTICA
Acta Pharm. Vol. 60 No. 1 pp. 1-128 Zagreb, March
2010
TABLE OF CONTENTS
ORIGINAL RESEARCH PAPERS
A. Delazar, L. Khodaie, J. Afshar, L. Nahar and S. D. Sarker
Isolation and free-radical-scavenging properties of cyanidin 3-O-glycosides from the fruits of Ribes biebersteinii Berl. . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . 1
R. N.
Sharma and S. S. Pancholi
RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13
N.
Jadhav, A. Pawar and A. Paradkar
Effect
of drug content and agglomerate size on tabletability and drug release
characteristics of bromhexine hydrochloride-talc agglomerates prepared by
crystallo-co-agglomeration. . 25
N. V. Patel, J. K. Patel and S. H. Shah
Box-Behnken
experimental design in the development of pectin–compritol ATO 888 compression
coated colon targeted drug delivery of mesalamine. . .
. . . . . . . . . . . . . . . . . . . . . 39
E. Reda El-Sawy, F. A. Bassyouni, S. H. Abu-Bakr, H.
M. Rady and M. M. Abdlla
Synthesis and biological activity of some new 1-benzyl and 1-benzoyl 3-heterocyclic indole derivatives. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
A. H. Mandour, E. R.
El-Sawy, K. H. Shaker and M. A. Mustafa
Synthesis, anti-inflammatory, analgesic and anticonvulsant activities of
1,8-dihydro-1-aryl-8-alkyl pyrazolo(3,4-b)indoles. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . .73
S. Bandari, C. M.
Eaga, A. Thadishetty and M. R. Yamsani
Formulation and evaluation of multiple tablets as a biphasic
gastroretentive floating drug delivery system for fenoverine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . 89
A.
Rasheed and C. K. Ashok Kumar
Design, synthesis, hydrolysis kinetics and phamacodynamic profiles of histidine and alanine conjugates of aceclofenac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
SHORT COMMUNICATIONS
V.
Mathur, R. Mudnaik, L. Barde, A. Roy, U. Shivhare and K. Bhusari
Formulation
and evaluation of controlled release antibiotic biodegradable implants for post
operative site delivery. . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . 111
N. Wszelaki, A. Kuciun and A. K. Kiss
Screening of traditional European herbal
medicines for acetylcholinesterase and butyrylcholinesterase inhibitory
activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . 119